ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other diseases.
ImmuneSensor Therapeutics has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in December 2022.
ImmuneSensor Therapeutics's investors include Cancer Prevention and Research Institute of Texas.
ImmuneSensor Therapeutics is headquartered in Dallas, United States.
ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other diseases.
ImmuneSensor Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImmuneSensor Therapeutics — Funding & Investors." VCBacked, December 5, 2022, https://www.vcbacked.co/company/immunesensor-therapeutics. Accessed October 4, 2026.
VCBacked. (2022). ImmuneSensor Therapeutics — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/immunesensor-therapeutics
{{cite web |title=ImmuneSensor Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/immunesensor-therapeutics |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated